THAPCA试验中儿童心脏骤停幸存者的神经学结局
在THAPCA两项多中心试验的181例12个月幸存者中,采用新型半定量PRCA表评估神经学结局,45%无/极轻度损害,21%重度损害;PRCA评分与VABS-II评分(r=-0.88)及认知评分(r=-0.72)强相关;院外心脏骤停、复苏后早期识别癫痫发作和出院时神经状态差与不良结局相关。
要点
- PRCA评分与VABS-II强相关(r=-0.88,p<0.0001),支持其作为儿童心脏骤停后神经结局评估工具。
- 12个月幸存者中45%无/极轻度损害,21%重度损害,提示结局谱广泛。
- 院外心脏骤停、复苏后早期识别癫痫发作和出院时神经状态差与不良结局相关。
核心结论
- PRCA是描述儿童心脏骤停所致急性脑病后神经学结局的可靠方法,提供整体半定量和域特异性损害评分。
研究设计与样本
- 两项多中心试验纳入48小时至18岁心脏骤停后仍昏迷的儿童,随机接受治疗性低温或治疗性常温。
- 神经科医生检查181例12个月幸存者,使用新型半定量PRCA表评估6个域,评分0(无缺陷)至21(最大缺陷)。
主要发现
- 神经结局PRCA评分分类:无/极轻度损害PRCA 0-3,81/179(45%);轻度损害PRCA 4-7,24/179(13%);中度损害PRCA 8-11,15/179(8%);重度损害PRCA 12-16,20/179(11%);极重度损害PRCA 17-21,39/179(21%)(2/181不完整)。
- VABS-II评分与PRCA类别强相关(r=-0.88,p<0.0001,Pearson相关系数),与认知评分强相关(r=-0.72,p<0.0001)。
- 与不良结局相关的因素包括院外心脏骤停、复苏后早期识别癫痫发作和出院时神经状态差。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To implement a standardized approach to characterize neurologic outcomes among 12-month survivors in the Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) trials. METHODS: Two multicenter trials enrolled children age 48 hours to 18 years who remained comatose after cardiac arrest (CA) occurring out-of-hospital (THAPCA-OH, NCT00878644) or in-hospital (THAPCA-IH, NCT00880087); patients were randomized to therapeutic hypothermia or therapeutic normothermia. The primary outcome, survival with favorable 12-month neurobehavioral outcome (Vineland Adaptive Behavior Scales [VABS-II]), did not differ between treatment groups in either trial. Neurologists examined 181 12-month survivors, described findings using the novel semi-quantitative Pediatric Resuscitation after Cardiac Arrest (PRCA) form, and rated findings in 6 domains; scores ranged from 0 (no deficits) to 21 (maximal deficits). PRCA scores were compared with 12-month VABS-II scores and cognitive scores. RESULTS: Neurologic outcome PRCA scores were classified as no/minimal impairment, PRCA 0-3, 81/179 (45%); mild impairment, PRCA 4-7, 24/179 (13%); moderate impairment, PRCA 8-11, 15/179 (8%); severe impairment, PRCA 12-16, 20/179 (11%); profound impairment, PRCA 17-21, 39/179 (21%) (2/181 incomplete). VABS-II scores correlated strongly with PRCA category (r = -0.88, p < 0.0001, Pearson correlation coefficient) and cognitive scores (r = -0.72, p < 0.0001). Factors associated with poor outcomes included out-of-hospital CA, seizure recognition in the early postarrest period, and poor neurologic status at hospital discharge. CONCLUSION: The PRCA provides a robust method for depicting neurologic outcomes after acute encephalopathy caused by CA in children. It provides a global semiquantitative rating of neurologic impairment and domain-specific impairment. The strong correlation with well-established neurobehavioral outcome measures supports its validity over a broad age range and wide spectrum of outcomes.
引用
- Ichord R, Silverstein FS, Slomine BS, et al. Neurologic outcomes in pediatric cardiac arrest survivors enrolled in the THAPCA trials. Neurology. 2018. PMID: 29884735. doi:10.1212/WNL.0000000000005773
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。